Cargando…

A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab

TNFAIP3 encodes the NF-κB regulatory protein A20. High-penetrance heterozygous mutations in TNFAIP3 cause a haploinsufficiency of A20 (HA20), inadequate inhibition of NF-κB pathway, and an early onset autoinflammatory disorder. However, the clinical phenotype of patients with HA20 varies greatly and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawless, Dylan, Pathak, Shelly, Scambler, Thomas Edward, Ouboussad, Lylia, Anwar, Rashida, Savic, Sinisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039542/ https://www.ncbi.nlm.nih.gov/pubmed/30022980 http://dx.doi.org/10.3389/fimmu.2018.01527

Ejemplares similares

Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three TNFRSF1A Mutations Results in Hyperresponsiveness to Lipopolysaccharide
por: Harrison, Stephanie R., et al.
Publicado: (2018)

Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder
por: Wu, Beibei, et al.
Publicado: (2021)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

Predicting the Occurrence of Variants in RAG1 and RAG2
por: Lawless, Dylan, et al.
Publicado: (2019)

Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab
por: Imaizumi, Chihiro, et al.
Publicado: (2022)

Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review
por: Zhong, Xiaojing, et al.
Publicado: (2023)

Glucose-6-Phosphatase Catalytic Subunit 3 (G6PC3) Deficiency Associated With Autoinflammatory Complications
por: Mistry, Anoop, et al.
Publicado: (2017)

Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease
por: Drepper, Michael, et al.
Publicado: (2013)

TNFAIP3 Plays a Role in Aging of the Hematopoietic System
por: Smith, Molly A., et al.
Publicado: (2020)

A NF-κB-Dependent Dual Promoter-Enhancer Initiates the Lipopolysaccharide-Mediated Transcriptional Activation of the Chicken Lysozyme in Macrophages
por: Witham, James, et al.
Publicado: (2013)

Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review
por: Watanabe, Eri, et al.
Publicado: (2016)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

TNFAIP3 Reduction-of-Function Drives Female Infertility and CNS Inflammation
por: Zammit, Nathan W., et al.
Publicado: (2022)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Heterochromatin protein 1 gamma and IκB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages
por: Thorne, James L., et al.
Publicado: (2012)

Identification of a Novel Mutation in TNFAIP3 in a Family With Poly-Autoimmunity
por: Rossi, Marianna Nicoletta, et al.
Publicado: (2022)

A Case Report on Adult-Onset Still’s Disease Successfully Treated With Tocilizumab: A Brief Review on its Safety and Efficacy
por: Nagalli, Shivaraj, et al.
Publicado: (2020)

Hereditary systemic autoinflammatory diseases and Schnitzler’s syndrome
por: Kacar, Mark, et al.
Publicado: (2019)

Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome
por: Pathak, Shelly, et al.
Publicado: (2020)

Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation
por: Lara-Reyna, Samuel, et al.
Publicado: (2019)

Activation mechanisms of monocytes/macrophages in adult-onset Still disease
por: Tsuboi, Hiroto, et al.
Publicado: (2022)

Two cases of multiple-drug-resistant adult-onset Still's disease treated successfully with tocilizumab - the relationship between interleukin 6 and 18
por: Sato, Kojiro, et al.
Publicado: (2012)

Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still's Disease with Liver Failure with No Response to Tocilizumab Therapy
por: Naniwa, Taio, et al.
Publicado: (2013)

Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease
por: Tsurukawa, Shinichiro, et al.
Publicado: (2016)

Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2018)

A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab
por: Lee, Ju Ho, et al.
Publicado: (2022)

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
por: Ouboussad, Lylia, et al.
Publicado: (2019)

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
por: Kacar, Mark, et al.
Publicado: (2020)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: A STROBE-compliant article
por: Wang, Chun-yan, et al.
Publicado: (2019)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Bibliometrics analysis on the research status and trends of adult-onset Still’s disease: 1921-2021
por: Qin, Aining, et al.
Publicado: (2022)

Case Report: A Rare Case of Elderly-Onset Adult-Onset Still’s Disease in a Patient With Systemic Lupus Erythematosus
por: Hirooka, Yasuaki, et al.
Publicado: (2022)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Case Report: A Novel TNFAIP3 Mutation Causing Haploinsufficiency of A20 With a Lupus-Like Phenotype
por: Shaheen, Zachary R., et al.
Publicado: (2021)

ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
por: Scambler, Thomas, et al.
Publicado: (2019)

Autoimmune hepatitis complicated by adult‐onset Still's disease during treatment with tocilizumab: A case report from acute onset to recurrence
por: Uchihara, Daiki, et al.
Publicado: (2023)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
por: Delplanque, Marion, et al.
Publicado: (2022)

mCRP as a Biomarker of Adult-Onset Still’s Disease: Quantification of mCRP by ELISA
por: Fujita, Chitose, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tb69atntl2hthk933n116f27h2